Davood Abdollahian, MD
Vascular & Interventional Radiology · Houston, TXNPI 1902199474
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $35,944 of the $51,611 with a category attached, or 69.6%. Boston Scientific accounts for 87.9% of it on its own, with 26 other manufacturers making up the rest. Among vascular & interventional radiology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 174 payments — averaging $296.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$45K
- Medical Device Business Services, Inc.$1K
- Siemens Medical Solutions USA, Inc.$1K
- Access Vascular Inc$650
- Histosonics, Inc.$582
- Merit Medical Systems Inc$576
- plus $2K from 21 others
What the payments were for
- Consulting fees$6501%
- Speaking & faculty fees$35,94470%
- Travel & lodging$6,26612%
- Food & beverage$8,71617%
- Education$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 104 | $45,360 |
| Medical Device Business Services, Inc. | 7 | $1,153 |
| Siemens Medical Solutions USA, Inc. | 10 | $1,009 |
| Access Vascular Inc | 1 | $650 |
| Histosonics, Inc. | 1 | $582 |
| Merit Medical Systems Inc | 1 | $576 |
| Biocompatibles, Inc. | 5 | $501 |
| Sirtex Medical Inc | 5 | $445 |
| Terumo Medical Corporation | 2 | $223 |
| Bard Peripheral Vascular, Inc. | 3 | $190 |
| Medtronic(2 entities) | 4 | $173 |
| Balt USA, LLC | 7 | $139 |
| Mozarc Medical US LLC | 3 | $92 |
| Stryker | 2 | $71 |
| Merck | 3 | $56 |
| Octapharma USA, Inc. | 1 | $54 |
| AbbVie | 3 | $51 |
| Angiodynamics, Inc. | 1 | $45 |
| Incyte Corporation | 2 | $37 |
| Johnson & Johnson | 2 | $35 |
| Eisai Inc. | 1 | $35 |
| Cardiva Medical, Inc. | 1 | $33 |
| Trisalus Life Sciences, Inc. | 1 | $26 |
| Covidien LP | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Varian Medical Systems, Inc. | 1 | $19 |
| Baylis Medical Technologies Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$21,772
- TheraSphere Y90 Glass Microspheres 10 GBq$7,178
- CERTUS 140 MICROWAVE ABLATION SYSTEM$1,006
- HYDROPICC$650
- HYDROMID$650
- HYDROPICC DUAL LUMEN$650
- VANNAS DEEP ACCESS VASCULAR SCISSORS$650
- Varian CRYOCARE TOUCH System$573
- THERASPHERE-BIO$399
- THERASPHERE$398
- EMBOLD Fibered$315
- SIR-Spheres Microspheres$262
- GlideWire$223
- Navicross$223
- Azur CX Detachable$223
- ANGIO-SEAL$223
- TheraSphere360_PI$167
- LAVA LES (Liquid Embolic System)$150
- EMBOZENE$148
- GENERAL - IO ABLATION$141
How this compares
$51,611 in reported general payments places this provider in the 90th percentile of 299 vascular & interventional radiology providers in Texas.
See all vascular & interventional radiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxybutynin Chloride ErOxybutynin Chloride | 18 | $133 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $103 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Houston
- Orlando DiazHouston$611K
- Rahul ShethHouston$410K
- Miguel MonteroHouston$386K
- Joshua KubanHouston$301K
- Peiman HabibollahiHouston$254K
- Ahmed Abdel AalHouston$147K
- Varshana GurusamyHouston$141K
- Armeen MahvashHouston$122K
- Andrew DoeHouston$106K
- Donald GarbettHouston$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.